1. Home
  2. PODD vs GRAB Comparison

PODD vs GRAB Comparison

Compare PODD & GRAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • GRAB
  • Stock Information
  • Founded
  • PODD 2000
  • GRAB 2012
  • Country
  • PODD United States
  • GRAB Singapore
  • Employees
  • PODD N/A
  • GRAB N/A
  • Industry
  • PODD Medical/Dental Instruments
  • GRAB Business Services
  • Sector
  • PODD Health Care
  • GRAB Consumer Discretionary
  • Exchange
  • PODD Nasdaq
  • GRAB Nasdaq
  • Market Cap
  • PODD 17.2B
  • GRAB 16.2B
  • IPO Year
  • PODD 2007
  • GRAB N/A
  • Fundamental
  • Price
  • PODD $257.00
  • GRAB $4.93
  • Analyst Decision
  • PODD Buy
  • GRAB Buy
  • Analyst Count
  • PODD 17
  • GRAB 9
  • Target Price
  • PODD $302.56
  • GRAB $5.81
  • AVG Volume (30 Days)
  • PODD 695.5K
  • GRAB 31.9M
  • Earning Date
  • PODD 05-08-2025
  • GRAB 04-30-2025
  • Dividend Yield
  • PODD N/A
  • GRAB N/A
  • EPS Growth
  • PODD 96.55
  • GRAB N/A
  • EPS
  • PODD 5.78
  • GRAB 0.00
  • Revenue
  • PODD $2,071,600,000.00
  • GRAB $2,917,000,000.00
  • Revenue This Year
  • PODD $20.53
  • GRAB $22.42
  • Revenue Next Year
  • PODD $17.42
  • GRAB $18.20
  • P/E Ratio
  • PODD $44.43
  • GRAB $3,903.40
  • Revenue Growth
  • PODD 22.07
  • GRAB 17.29
  • 52 Week Low
  • PODD $160.19
  • GRAB $2.98
  • 52 Week High
  • PODD $289.46
  • GRAB $5.72
  • Technical
  • Relative Strength Index (RSI)
  • PODD 50.41
  • GRAB 62.45
  • Support Level
  • PODD $252.88
  • GRAB $4.74
  • Resistance Level
  • PODD $260.96
  • GRAB $4.98
  • Average True Range (ATR)
  • PODD 7.68
  • GRAB 0.21
  • MACD
  • PODD 1.34
  • GRAB 0.05
  • Stochastic Oscillator
  • PODD 65.40
  • GRAB 93.03

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.

About GRAB Grab Holdings Limited

Founded in 2012, Grab provides ride-sharing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast-Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging commission to both sides. Grab has a leading market share in and derives 89% of its revenue from its core businesses, ride-sharing and food delivery. Singapore and Malaysia contributed 58% of revenue as of end-2021. Grab's main competitors in Southeast Asia are Foodpanda and Gojek, the ride-sharing arm of GoTo. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.

Share on Social Networks: